Equity
Treasury Stock
Royalty Pharma Treasury Stock increased by 3.7% to $2.71M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 2.1%, from $2.65M to $2.71M. Over 5 years (FY 2020 to FY 2025), Treasury Stock shows an upward trend with a 2.4% CAGR.
Analysis
StatementBalance Sheet Statement
SectionEquity
CategoryCapital Allocation
SignalContext dependent
VolatilityModerate
First reportedQ4 2021
Last reportedQ1 2026
How to read this metric
An increase indicates active share buybacks, which often signals management's confidence in the company's value.
Detailed definition
This represents the cost of shares that the company has repurchased from the open market and currently holds in its own...
Peer comparison
Commonly used by mature companies to manage earnings per share and return excess cash to investors.
Metric ID:
treasury_stockHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.66M | $2.69M | $2.72M | $2.74M | $2.75M | $2.79M | $2.81M | $2.83M | $2.63M | $2.62M | $2.63M | $2.65M | $2.66M | $2.66M | $2.66M | $2.65M | $2.61M | $2.61M | $2.61M | $2.71M |
| QoQ Change | — | +0.9% | +1.1% | +0.8% | +0.6% | +1.3% | +0.6% | +0.8% | -7.0% | -0.2% | +0.2% | +1.0% | +0.3% | -0.2% | +0.2% | -0.3% | -1.6% | -0.0% | +0.0% | +3.7% |
| YoY Change | — | — | — | — | +3.4% | +3.8% | +3.4% | +3.4% | -4.5% | -5.9% | -6.3% | -6.2% | +1.2% | +1.3% | +1.3% | +0.0% | -1.8% | -1.7% | -1.9% | +2.1% |
Range$2.61M – $2.83M
CAGR+0.4%
Avg YoY Growth-0.5%
Median YoY Growth+0.6%
Current Streak2 quarters growth
Treasury Stock at Other Companies
Frequently Asked Questions
- What is Royalty Pharma's treasury stock?
- Royalty Pharma (RPRX) reported treasury stock of $2.71M in Q1 2026.
- How has Royalty Pharma's treasury stock changed year-over-year?
- Royalty Pharma's treasury stock increased by 2.1% year-over-year, from $2.65M to $2.71M.
- What is the long-term trend for Royalty Pharma's treasury stock?
- Over 5 years (2020 to 2025), Royalty Pharma's treasury stock has grown at a 2.4% compound annual growth rate (CAGR), from $2.32M to $2.61M.
- What does treasury stock mean?
- The cost of shares the company has bought back from the market and is holding.